97 related articles for article (PubMed ID: 25312300)
1. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T
Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis.
Goyal A; O'Leary D; Foss F
Bone Marrow Transplant; 2024 Jan; 59(1):41-51. PubMed ID: 37853164
[TBL] [Abstract][Full Text] [Related]
3. A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
Jacobsen ED; Kim HT; Ho VT; Cutler CS; Koreth J; Fisher DC; Armand P; Alyea EP; Freedman AS; Soiffer RJ; Antin JH
Ann Oncol; 2011 Jul; 22(7):1608-1613. PubMed ID: 21252059
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
de Masson A; Beylot-Barry M; Ram-Wolff C; Mear JB; Dalle S; d'Incan M; Ingen-Housz-Oro S; Orvain C; Abraham J; Dereure O; Charbonnier A; Cornillon J; Longvert C; Barete S; Boulinguez S; Wierzbicka-Hainaut E; Aubin F; Rubio MT; Bernard M; Schmidt-Tanguy A; Houot R; Pham-Ledard A; Michonneau D; Brice P; Labussière-Wallet H; Bouaziz JD; Grange F; Moins-Teisserenc H; Jondeau K; Michel L; Mourah S; Battistella M; Daguindau E; Loschi M; Picard A; Franck N; Maillard N; Huynh A; Nguyen S; Marçais A; Chaby G; Ceballos P; Le Corre Y; Maury S; Bay JO; Adamski H; Bachy E; Forcade E; Socié G; Bagot M; Chevret S; Peffault de Latour R; ; ;
Lancet; 2023 Jun; 401(10392):1941-1950. PubMed ID: 37105210
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides and Sézary syndrome: a population-wide study on prevalence and health care use in Finland in 1998-2016.
Keto J; Hahtola S; Linna M; Väkevä L
BMC Health Serv Res; 2021 Feb; 21(1):166. PubMed ID: 33618714
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma.
Goyal A; Foss F
Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371
[TBL] [Abstract][Full Text] [Related]
7. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J; Assaf C; Bagot M; Cozzio A; Dummer R; Guenova E; Gniadecki R; Hodak E; Jonak C; Klemke CD; Knobler R; Morrris S; Nicolay JP; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Wehkamp U; Whittaker S; Willemze R; Trautinger F
Eur J Cancer; 2023 Dec; 195():113343. PubMed ID: 37890355
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
Titou H; Bouhamidi A
Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
[TBL] [Abstract][Full Text] [Related]
9. Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome.
Morris SL; Thomas BR; Palanicawandar R; Whittaker S; Child F; Wain M; Sim V; Szydlo R; Mangar S; Olavarria E; Lozano Cerrada S; Muzamil A; Kanfer E
Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38472408
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.
Levy Yurkovski I; Rokach L; Melamed G; Alapi H; Gazit S; Patalon T; Tadmor T
Acta Haematol; 2023; 146(6):496-503. PubMed ID: 37517402
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors and Survival Outcomes Among Patients With Mycosis Fungoides in China: A 12-Year Review.
Chen Z; Lin Y; Qin Y; Qu H; Zhang Q; Li Y; Wen Y; Sun J; Tu P; Gao P; Wang Y
JAMA Dermatol; 2023 Oct; 159(10):1059-1067. PubMed ID: 37585188
[TBL] [Abstract][Full Text] [Related]
12. Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
Elsayad K; Weishaupt C; Moustakis C; Danzer MF; Müller EC; Rolf D; Stranzenbach R; Livingstone E; Booken N; Stadler R; Eich HT
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):164-170. PubMed ID: 36893819
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome.
Ranjbaryan M; Calvani J; Louveau B; Cuccuini W; Battesti G; Bozonnat A; Moins-Teisserenc H; Michonneau D; Bagot M; Ram-Wolff C; Dobos G; Mourah S; Battistella M; de Masson A
Eur J Dermatol; 2023 Aug; 33(4):439-440. PubMed ID: 37823502
[No Abstract] [Full Text] [Related]
14. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.
Mazzeo E; Rubino L; Buglione M; Antognoni P; Magrini SM; Bertoni F; Parmiggiani M; Barbieri P; Bertoni F
Rep Pract Oncol Radiother; 2014 Mar; 19(2):77-91. PubMed ID: 24936325
[TBL] [Abstract][Full Text] [Related]
15. Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sézary Syndrome Compared to a Matched Control Cohort.
Johnson CM; Talluru SM; Bubic B; Colbert M; Kumar P; Tsai HL; Varadhan R; Rozati S
JID Innov; 2023 Nov; 3(6):100219. PubMed ID: 38116332
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS).
Atilla E; Atilla PA; Bozdag SC; Yuksel MK; Toprak SK; Topcuoglu P; Akay BN; Sanli H; Gurman G; Ozcan M
Int J Hematol; 2017 Sep; 106(3):426-430. PubMed ID: 28466385
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome.
Virmani P; Zain J; Rosen ST; Myskowski PL; Querfeld C
Dermatol Clin; 2015 Oct; 33(4):807-18. PubMed ID: 26433851
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides.
Elliott J; Ahlawat S; Prince HM; Kennedy G; Wells J; Huang G; Collins J; Bardy P; Van Der Weyden C; Ritchie D; Khot A
Bone Marrow Transplant; 2022 Nov; 57(11):1724-1726. PubMed ID: 36028756
[No Abstract] [Full Text] [Related]
19. Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas.
Dumont M; Peffault de Latour R; Ram-Wolff C; Bagot M; de Masson A
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023002
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis.
Dimitriou F; Schanz U; Nair G; Kimeswenger S; Brüggen MC; Hoetzenecker W; French LE; Dummer R; Cozzio A; Guenova E
Front Med (Lausanne); 2020; 7():290. PubMed ID: 32714935
[No Abstract] [Full Text] [Related]
[Next] [New Search]
